Brief: Geneuro Completes Patient Recruitment In Temelimab Phase 2 Multiple Sclerosis Trial At The Karolinska Institutet’S Academic Specialist Center
18/02/2021 07:09
Feb 18 (Reuters) - Geneuro SA GNRO.PA :
* GENEURO COMPLETES PATIENT RECRUITMENT IN TEMELIMAB PHASE 2
MULTIPLE SCLEROSIS TRIAL AT THE KAROLINSKA INSTITUTET’S ACADEMIC
SPECIALIST CENTER (ASC)
Source text for Eikon: ID:nBw3yDRgqa
Further company coverage: GNRO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Geneuro SA
See all newsBrief: Geneuro SA Postpones Publication Of Half-Yearly Financial Report
Brief: Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium
Brief: Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas
Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
Brief: Geneuro announces EUR 5 Mln private placement